课题基金 / 基金详情

BIOLOGICAL EFFECT AND CLINICAL EFFICACY OF OCTREOTIDE, ANALOG OF SOMATOSTATIN

BIOLOGICAL EFFECT AND CLINICAL EFFICACY OF OCTREOTIDE, ANALOG OF SOMATOSTATIN
生长抑素类似物奥曲肽的生物学效应和临床疗效
批准号：
5222203
负责人：
ALAN C MOSES
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5222203
关键词：
acromegaly clinical research drug screening /evaluation endocrine disorder endocrine disorder chemotherapy hormone therapy human subject human therapy evaluation pharmacokinetics somatostatin

项目摘要

项目成果

ALAN C MOSES的其他基金

相似基金

相关文献

中文摘要
翻译
这项协议将研究药效学和生物学 生长抑素的强效类似物奥曲肽的疗效 延长人类的半衰期。奥曲肽将在以下患者中进行检查 肢端肥大症和多种罕见的内分泌高分泌状态。
英文摘要
This protocol will investigate the pharmacodynamics and biological efficacy of a potent analog of somatostatin, octreotide, that has a prolonged half-life in man. Octreotide will be examined in patients with acromegaly and a variety of rare endocrine hypersecretion states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES
CHARACTERIZATION OF INSULIN & INSULIN LIKE GROWTH FACTOR RESPONSES
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM
PILOT STUDY OF A NOVEL, NONINVASIVE METHOD OF BLOOD GLUCOSE MONITORING
海外基金